Nautilus Biotechnology, Inc. (NASDAQ:NAUT) Q1 2024 Earnings Call Transcript April 30, 2024 Nautilus Biotechnology, Inc. beats earnings expectations. Reported EPS is $-0.00015, expectations were $-0.16. NAUT isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good day and thank you for […]
Thermo Fisher Scientific Inc. is helping proteomics researchers increase productivity and free up time for more value-added activities when generating high-quality samples for analysis, using a new automated sample preparation system that integrates within any LC-MS workflow.
The agreement with Thermo Fisher Scientific is providing life science researchers with comprehensive mass spectrometry solutions to gain deep proteomic insights at a large scale Biognosys, a leading
The agreement with Thermo Fisher Scientific is providing life science researchers with comprehensive mass spectrometry solutions to gain deep proteomic insights at a large scale Biognosys, a leading
Highlights include workflow innovations in Plasma Proteomics and Immunopeptidomics, and enhanced Proteomics data analysis with Spectronaut Biognosys, a leading inventor and developer of mass spectrometry-based